Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00102
Species: Homo sapiens
Position : chr21:43361800-43362620
Year: 2021
Title: Enhancer release and retargeting activates disease-susceptibility genes
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Normal
Disease Name: --
PMID:  34040254
MONDO:
Tissue: Mammary gland
Tissue Ontology ID: UBERON:0001911
Cell Source: MCF-7
CVCL ID: CVCL_0031
Cell Type: estrogen-responsive breast epithelial cell
Cell Ontology ID: CL:0001070
Experiment Type: CRISPR-Cas9 locus deletion, 4C-seq chromatin interaction, ChIP-qPCR, siRNA cohesin knockdown
High Throughput Method: GRO-seq, CTCF ChIA-PET, H3K4me3/H3K4me1 ChIP-seq
Low Throughput Method: RT-qPCR, clonal cell line generation, chromatin immunoprecipitation
About Target Gene
Target gene : TFF1
About TF
TF name : FOXA1
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
FOXA1 AndrogenReceptor netpath 167
FOXA1 Direct p53 effectors pid 141
FOXA1 FOXA1 transcription factor network pid 45
FOXA1 FOXA2 and FOXA3 transcription factor networks pid 45
FOXA1 Hs_Endoderm_Differentiation_WP2853_88152 wikipathways 62
Enhancer Associated Network
Overlapping Enhancers (hg19) 1 found
Enhancer ID Position Tissue Cell Disease
E_00101 chr21:43361800-43362620 Mammary gland estrogen-responsive breast epithelial cell --
Expression of Target Genes for the Enhancer